RPS13P4

Across TCGA pan-cancer cohorts, RPS13P4 RNA is linked to patient survival in 18 of 34 cancer types, making it the most broadly survival-associated RPS13P4 data layer.

The strongest signal is observed in uterine carcinosarcoma (UCS), where higher RPS13P4 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated RPS13P4 expression acts as an unfavorable survival marker, although some lineages such as PAAD and SKCM show a favorable association.

UCS, UVM, and ACC are the cancer types where RPS13P4 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
UCS	OS	Tertile	All	0.164	0.645	<.001	108	view →
UVM	DFS	Tertile	All	0.205	0.772	<.001	72	view →
ACC	OS	Tertile	III,IV	0.145	0.766	<.001	45	view →
KIRP	DFS	Tertile	IV	0.088	0.502	<.001	36	view →
THCA	OS	Tertile	All	0.648	0.967	.001	36	view →
LIHC	DFS	Tertile	III,IV	0.090	0.342	<.001	27	view →
COAD	OS	Tertile	III,IV	0.187	0.602	.012	18	view →
MESO	OS	Tertile	III,IV	0.417	0.582	.027	18	view →
HNSC	OS	Tertile	IV	0.180	0.675	<.001	18	view →
ESCA	OS	Quartile	All	0.611	0.808	.020	14	view →
READ	OS	Tertile	IV	0.289	0.899	<.001	9	view →
PCPG	OS	Tertile	All	0.888	1.000	.002	9	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 18 lineages.

RPS13P4–UCS (OS)

Open the UCS breakdown →